| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $9.2M | +229.7% |
| SG&A Expense | $6.7M | -22.1% |
| Operating Income | -$15.9M | +19.1% |
| Pre-tax Income | -$12.5M | +10.7% |
| Income Tax | $0 | — |
| Net Income | -$12.5M | +10.7% |
| EPS (Basic) | -$2.46 | +54.7% |
| EPS (Diluted) | -$2.46 | +54.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.4M | -32.8% |
| Current Assets | $22.5M | -32.9% |
| Total Assets | $22.8M | -32.1% |
| Current Liabilities | $6.0M | -49.4% |
| Total Liabilities | $6.1M | -48.3% |
| Stockholders' Equity | $16.7M | -23.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.8M | +7.8% |
| Capital Expenditures | $50K | — |
| Investing Cash Flow | -$50K | -725.0% |
| Financing Cash Flow | -$80K | -100.3% |
| Free Cash Flow | -$10.8M | — |